A study to evaluate the effects of BGF and GFF on Specific Image based Airway Volumes and Resistance in Subjects with Moderate to Severe COPD

Trial Identifier: D5980C00019
Sponsor: AstraZeneca
NCTID:: NCT03836677
Start Date: February 2019
Primary Completion Date: November 2019
Study Completion Date: November 2019
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Dutch Translation
French Translation

Trial Locations

Country Location
Belgium Erpent, Belgium, 5101
Netherlands EINDHOVEN, Netherlands, 5623 EJ
Netherlands GRONINGEN, Netherlands, 9713 GZ
Netherlands Zutphen, Netherlands, 7207 AE